A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy - Nature Genetics
- ️Manley, James L
- ️Sun Jun 29 2003
References
Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155–165 (1995).
Monani, U.R. et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8, 1177–1183 (1999).
Lorson, C.L., Hahnen, E., Androphy, E.J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 96, 6307–6311 (1999).
Cartegni, L. & Krainer, A.R. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 30, 377–384 (2002).
Lorson, C.L. & Androphy, E.J. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet. 9, 259–265 (2000).
Hofmann, Y., Lorson, C.L., Stamm, S., Androphy, E.J. & Wirth, B. Htra2-β1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl. Acad. Sci. USA 97, 9618–9623 (2000).
Tacke, R., Tohyama, M., Ogawa, S. & Manley, J.L. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 93, 139–148 (1998).
Manley, J.L. & Tacke, R. SR proteins and splicing control. Genes Dev. 10, 1569–1579 (1996).
Caceres, J.F., Stamm, S., Helfman, D.M. & Krainer, A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265, 1706–1709 (1994).
Wang, J. & Manley, J.L. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1, 335–346 (1995).
Wang, J., Takagaki, Y. & Manley, J.L. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev. 10, 2588–2599 (1996).
Wang, J., Xiao, S.H. & Manley, J.L. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing. Genes Dev. 12, 2222–2233 (1998).
Caputi, M., Mayeda, A., Krainer, A.R. & Zahler, A.M. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 18, 4060–4067 (1999).
Del Gatto-Konczak, F., Olive, M., Gesnel, M.C. & Breathnach, R. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19, 251–260 (1999).
Matter, N. et al. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways. J. Biol. Chem. 275, 35353–35360 (2000).
Hou, V.C. et al. Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. EMBO J. 21, 6195–6204 (2002).
Burd, C.G. & Dreyfuss, G. RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13, 1197–1204 (1994).
Bilodeau, P.S., Domsic, J.K., Mayeda, A., Krainer, A.R. & Stoltzfus, C.M. RNA splicing at human immunodeficiency virus type 1 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J. Virol. 75, 8487–8497 (2001).
Mayeda, A., Munroe, S.H., Caceres, J.F. & Krainer, A.R. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J. 13, 5483–5495 (1994).
Hutchison, S., LeBel, C., Blanchette, M. & Chabot, B. Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5′ splice site selection in the hnRNP A1 mRNA precursor. J. Biol. Chem. 277, 29745–29752 (2002).
Hofmann, Y. & Wirth, B. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-β1. Hum. Mol. Genet. 11, 2037–2049 (2002).
Young, P.J. et al. SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 β1. Hum. Mol. Genet. 11, 577–587 (2002).
Tange, T.O., Damgaard, C.K., Guth, S., Valcarcel, J. & Kjems, J. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J. 20, 5748–5758 (2001).
Cartegni, L., Chew, S.L. & Krainer, A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285–298 (2002).
Tacke, R. & Manley, J.L. Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11, 358–362 (1999).
Dreyfuss, G., Kim, V.N. & Kataoka, N. Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 3, 195–205 (2002).
Wilkinson, M.F. & Shyu, A.B. RNA surveillance by nuclear scanning? Nat. Cell Biol. 4, E144–E147 (2002).
Tacke, R. & Manley, J.L. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14, 3540–3551 (1995).
Santoro, S.W. & Joyce, G.F. A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. USA 94, 4262–4266 (1997).
Elbashir, S.M., Harborth, J., Weber, K. & Tuschl, T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199–213 (2002).